A noninvasive ultrasound device restored heart rhythm in animal models and engineered human heart cells, paving the way for ...
Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam ...
UC Davis Director of Pediatric Electrophysiology Dan Cortez has set another world record: He is the first to implant a dual chamber leadless pacemaker in a child. His case report was published this ...
Medtronic has competition in the U.S. market for leadless pacemakers. The Dublin, Ireland-based company made history nearly six years ago to the day when FDA approved the Micra leadless pacemaker on ...
Wireless or leadless pacemakers, commonly implanted in adults, may be a safe and effective short-term option for children with slow heartbeats, according to new research published today in Circulation ...
Leadless pacemakers and implantable cardioverter defibrillators (ICDs) are expected to deliver a welcome jolt to the cardiac rhythm management (CRM) market in the coming years owing to their small ...
An experimental leadless pacemaker is able to capture enough energy from the heart to partially power the device, according to results from a new proof-of-concept study. The prototype device harvested ...
A leadless right-ventricular pacemaker continued to show an edge over conventional transvenous pacemakers by triggering a substantially reduced rate of complications during the 6 months following ...
Photo Credit: Adapted from Brown K. TCT 564: A new perspective: intracardiac echocardiographic guidance for the implantation of a left atrial appendage occluder device (Watchman) with a leadless ...
Pediatric cardiologists have implanted a dual chamber leadless pacemaker in a child. UC Davis Director of Pediatric Electrophysiology Dan Cortez has set another world record: He is the first to ...
Every year more than one million people receive a pacemaker. Until now, leadless versions were only available for 20% of these patients. However, thanks to an international consortium led by Amsterdam ...